257 related articles for article (PubMed ID: 15181323)
1. Role of iodine-131 MIBG scanning in the management of paediatric patients with neuroblastoma.
Shah Syed GM; Naseer H; Usmani GN; Cheema MA
Med Princ Pract; 2004; 13(4):196-200. PubMed ID: 15181323
[TBL] [Abstract][Full Text] [Related]
2. Radioiodinated meta-iodobenzylguanidine in the diagnosis of childhood neuroblastoma.
Claudiani F; Stimamiglio P; Bertolazzi L; Cabria M; Conte M; Villavecchia GP; Garaventa A; Lanino E; De Bernardi B; Scopinaro G
Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):21-4. PubMed ID: 9002744
[TBL] [Abstract][Full Text] [Related]
3. 131I-MIBG in the diagnosis of primary and metastatic neuroblastoma.
El-Maghraby T
Gulf J Oncolog; 2007 Jul; (2):33-41. PubMed ID: 20084722
[TBL] [Abstract][Full Text] [Related]
4. The role of 131 iodine-metaiodobenzylguanidine scanning in the correlative imaging of patients with neuroblastoma.
Andrich MP; Shalaby-Rana E; Movassaghi N; Majd M
Pediatrics; 1996 Feb; 97(2):246-50. PubMed ID: 8584386
[TBL] [Abstract][Full Text] [Related]
5. Skeletal assessment in neuroblastoma--the pitfalls of iodine-123-MIBG scans.
Gordon I; Peters AM; Gutman A; Morony S; Dicks-Mireaux C; Pritchard J
J Nucl Med; 1990 Feb; 31(2):129-34. PubMed ID: 2313350
[TBL] [Abstract][Full Text] [Related]
6. Iodine-131-metaiodobenzylguanidine and bone scintigraphy for the detection of neuroblastoma.
Shulkin BL; Shapiro B; Hutchinson RJ
J Nucl Med; 1992 Oct; 33(10):1735-40. PubMed ID: 1403138
[TBL] [Abstract][Full Text] [Related]
7. In-111 pentetreotide scintigraphy in patients with neuroblastoma. Comparison with I-131 MIBG, N-Myc oncogene amplification, and patient outcome.
Shalaby-Rana E; Majd M; Andrich MP; Movassaghi N
Clin Nucl Med; 1997 May; 22(5):315-9. PubMed ID: 9152532
[TBL] [Abstract][Full Text] [Related]
8. [Sensitivity and specificity of meta-iodobenzylguanidine (mIBG) scintigraphy in the evaluation of neuroblastoma: analysis of 115 cases].
Lumbroso J; Guermazi F; Hartmann O; Coornaert S; Rabarison Y; Lemerle J; Parmentier C
Bull Cancer; 1988; 75(1):97-106. PubMed ID: 3359060
[TBL] [Abstract][Full Text] [Related]
9. [Scintigraphy with radioiodinated meta-iodobenzylguanidine in the diagnosis of neuroblastoma].
Müller-Gärtner HW; Erttmann R; Helmke K
Nuklearmedizin; 1985 Dec; 24(5-6):222-6. PubMed ID: 3912731
[TBL] [Abstract][Full Text] [Related]
10. A comparison of iodine-123 meta-iodobenzylguanidine scintigraphy and single bone marrow aspiration biopsy in the diagnosis and follow-up of 26 children with neuroblastoma.
Osmanagaoglu K; Lippens M; Benoit Y; Obrie E; Schelstraete K; Simons M
Eur J Nucl Med; 1993 Dec; 20(12):1154-60. PubMed ID: 8299650
[TBL] [Abstract][Full Text] [Related]
11. Does I-131-MIBG underestimate skeletal disease burden in neuroblastoma?
Barai S; Bandopadhayaya GP; Malhotra A; Agarwal S; Kumar R; Dhanapathi H
J Postgrad Med; 2004; 50(4):257-60; discussion 260-1. PubMed ID: 15623965
[TBL] [Abstract][Full Text] [Related]
12. 18F-FDG PET/CT and 123I-metaiodobenzylguanidine imaging in high-risk neuroblastoma: diagnostic comparison and survival analysis.
Papathanasiou ND; Gaze MN; Sullivan K; Aldridge M; Waddington W; Almuhaideb A; Bomanji JB
J Nucl Med; 2011 Apr; 52(4):519-25. PubMed ID: 21421719
[TBL] [Abstract][Full Text] [Related]
13. Pitfalls and solutions in neuroblastoma diagnosis using radioiodine MIBG: our experience about 50 cases.
Bouvier JF; Philip T; Chauvot P; Brunat Mentigny M; Ducrettet F; Maïassi N; Lahneche BE
Prog Clin Biol Res; 1988; 271():707-20. PubMed ID: 3261425
[TBL] [Abstract][Full Text] [Related]
14. Extending positron emission tomography scan utility to high-risk neuroblastoma: fluorine-18 fluorodeoxyglucose positron emission tomography as sole imaging modality in follow-up of patients.
Kushner BH; Yeung HW; Larson SM; Kramer K; Cheung NK
J Clin Oncol; 2001 Jul; 19(14):3397-405. PubMed ID: 11454888
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the utility of
Gauguet JM; Pace-Emerson T; Grant FD; Shusterman S; DuBois SG; Frazier AL; Voss SD
Pediatr Blood Cancer; 2017 Nov; 64(11):. PubMed ID: 28449267
[TBL] [Abstract][Full Text] [Related]
16. Iodine-131 metaiodobenzylguanidine scintigraphy for localization of lesions in children with neuroblastoma: comparison with computed tomography and ultrasonography.
Lastoria S; Maurea S; Caracò C; Vergara E; Maurelli L; Indolfi P; Casale F; di Tullio MT; Salvatore M
Eur J Nucl Med; 1993 Dec; 20(12):1161-7. PubMed ID: 8299651
[TBL] [Abstract][Full Text] [Related]
17. Scanning with iodine-131 MIBG in children with solid tumors: an initial appraisal.
Hadley GP; Rabe E
J Nucl Med; 1986 May; 27(5):620-6. PubMed ID: 3712077
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of stage 4 neuroblastoma patients by means of MIBG and 99mTc-MDP scintigraphy.
Turba E; Fagioli G; Mancini AF; Rosito P; Galli A; Alvisi P
J Nucl Biol Med (1991); 1993 Sep; 37(3):107-14. PubMed ID: 8218456
[TBL] [Abstract][Full Text] [Related]
19. Whole-body MRI of paediatric malignant tumours: comparison with conventional oncological imaging methods.
Goo HW; Choi SH; Ghim T; Moon HN; Seo JJ
Pediatr Radiol; 2005 Aug; 35(8):766-73. PubMed ID: 15864576
[TBL] [Abstract][Full Text] [Related]
20. I-131 MIBG imaging after bone marrow transplantation for neuroblastoma.
Englaro EE; Gelfand MJ; Harris RE; Smith HS
Radiology; 1992 Feb; 182(2):515-20. PubMed ID: 1732972
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
